Medical Condition

chronic obstructive pulmonary disease

Total Trials

10

Recruiting Now

10

Trial Phases

Phase 2, Phase 3, Phase 4

ClinicalMetric tracks all active clinical trials for chronic obstructive pulmonary disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — chronic obstructive pulmonary disease Clinical Trials

How many clinical trials are currently recruiting for chronic obstructive pulmonary disease?

ClinicalMetric currently tracks 10 actively recruiting clinical trials for chronic obstructive pulmonary disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for chronic obstructive pulmonary disease?

chronic obstructive pulmonary disease research spans Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a chronic obstructive pulmonary disease clinical trial?

Eligibility criteria for chronic obstructive pulmonary disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

Phase 3

Phase 4

Top Sponsors

Centre Hospitalier Intercommunal Creteil 1 trial

Seoul National University Hospital 1 trial

CHU de Reims 1 trial

University of Alberta 1 trial

AstraZeneca 1 trial

Recruiting Clinical Trials

NCT05227547

Recruiting

Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease

Centre Hospitalier Intercommun...

View Trial →

NCT03120481

Recruiting

Controls for Respiratory Diseases

Seoul National University Hosp...

View Trial →

NCT07274631

Recruiting

A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD

University of Alberta

View Trial →

NCT06862206

Recruiting

This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Accelerated Pulmonary Rehabilitation in the Preoperative Period

University of Vermont

View Trial →

NCT07762573

Recruiting

Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective Study

Nanfang Hospital, Southern Med...

View Trial →

NCT07190222 Phase 3

Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Enrollment

942 pts

Location

United States, Argen...

Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels

Enrollment

135 pts

Location

Germany, Netherlands...

Sponsor

Maria Joyera Rodríguez

View Trial →

NCT06275230

Recruiting

Establishment of Human Lung Stem Cell Proliferation System and Organoid Construction in COPD

China-Japan Friendship Hospita...

View Trial →

Related Conditions

asthma (2) bronchiectasis (2) lung cancer (2) chronic obstructive lung disease (1) idiopathic pulmonary fibrosis (1) nontuberculous mycobacterium infection (1) cystic fibrosis (1) primary ciliary dyskinesia (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology